Atlas Trials

TiTAN-1: Safety, Proliferation and Persistence of GEN-011 Autologous Cell Therapy

Clinical trial NCT04596033 · TERMINATED

Trial details

NCT number
NCT04596033
Sponsor
Genocea Biosciences, Inc.
Status
TERMINATED
Phase
Phase 1
Study type
INTERVENTIONAL
MelanomaNon-small Cell Lung CancerSquamous Cell Carcinoma of Head and NeckUrothelial CarcinomaRenal Cell CarcinomaSmall-cell Lung CancerCutaneous Squamous Cell CarcinomaAnal Squamous Cell CarcinomaMerkel Cell Carcinoma
Start date
2020-11-11
Primary completion
2022-06-27
Enrollment
49

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.